‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness

On May 24, 2022, the U.S. Centers for Disease Control and Prevention (CDC) issued a health advisory to health care providers, public health departments and the general public regarding Pfizer’s antiviral drug Paxlovid, designed to treat symptoms of COVID-19. The advisory warns that some people who take Paxlovid may experience a recurrence of COVID symptoms …

‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness Read More »